European Authorities Seized Counterfeit Medicines in 2025
Officials recovered over €33 million in fake drugs as criminal networks expanded their distribution operations across Europe.
Updated on Sept. 29, 2026 in Drug Crime

Live Poll
Do you trust online marketplaces to effectively prevent the sale of dangerous counterfeit products?
Throughout 2025, European authorities seized more than €33 million in counterfeit medicines. Criminal networks used online marketplaces and small parcel shipments to circulate these illicit goods.
Why it matters
Criminal syndicates are increasingly capitalizing on high profit margins and low legal risks to distribute dangerous products. Inadvertent promotion by social media influencers has further amplified consumer demand for these counterfeit items.
European authorities successfully intercepted over €33 million worth of counterfeit medicines in 2025. Investigations remain ongoing regarding the specific criminal networks responsible for the supply chains.
The players
European Authorities
These regional law enforcement and regulatory agencies are responsible for monitoring illicit trade and public health across European member states.
The details
Fake oxycodone pills containing nitazenes were discovered in the Netherlands, posing a lethal risk to consumers. These synthetic opioids are up to 500 times more potent than morphine and can cause fatal respiratory failure within minutes of exposure.
Timeline
EU authorities carried out medicine seizures throughout 2025.
Legal Context
This criminal activity follows a pattern of complex supply chain exploitation seen in previous public health crises, such as the 2018 Cyclospora outbreak linked to McDonald's salads. Law enforcement faces persistent challenges as traffickers utilize anonymous shipping methods to bypass international borders.
Consumers are advised to exercise extreme caution when purchasing medication from unauthorized online sources, as fake products may contain lethal synthetic additives. Authorities suggest verifying all pharmaceutical products through licensed pharmacies to ensure medical safety.
The takeaway
The rise of counterfeit opioids highlights the severe danger of bypassing regulated medical supply chains for prescription drugs. Consumers should remain vigilant, as even products marketed as common pharmaceuticals may contain potent, life-threatening synthetic substances.
Further reading
For more information on illicit pharmaceutical trends, visit the Drug Crime section.
Source note: This article includes information reported by Euronews English.
Live Poll
Do you trust online marketplaces to effectively prevent the sale of dangerous counterfeit products?







